Literature DB >> 32417360

Are we missing opioid-related deaths among people with HIV?

William C Becker1, Kirsha S Gordon2, E Jennifer Edelman3, Joseph L Goulet2, Robert D Kerns2, Brandon D L Marshall4, David A Fiellin3, Amy C Justice5, Janet P Tate2.   

Abstract

BACKGROUND: Ascertainment of unnatural and overdose death may be unreliable among individuals with life-limiting conditions such as HIV infection. We sought to determine whether the relationship between opioid use and unnatural death differs among decedents with HIV (DWH) and those without.
METHODS: Decedents in the Veterans Aging Cohort Study (VACS) from 2002 to 14 were linked to the National Death Index cause of death file. Deaths were classified as unnatural, overdose (a subset of unnatural), or other. We defined opioid use as self-reported illicit use or receipt of prescribed opioids. Treating unnatural and overdose deaths as outcomes, we calculated odds ratios for opioid exposure by HIV status, with and without adjustment for disease severity using VACS Index.
RESULTS: Among 561 decedents without HIV (DWOH) and 884 DWH, 11 % and 8 % respectively were classified as unnatural deaths and 4 % and 2 % were classified as overdose deaths. Among DWOH, opioid use was associated with 2-fold greater odds of unnatural (OR 2.3; 95 % CI 1.3-4.0) and 4-fold greater odds of overdose death (OR 4.5; 95 % CI 1.5-13.7); in adjusted analyses, opioid use was associated with unnatural death (OR 2.6; 95 % CI 1.3-4.9) and with overdose (OR 4.2; 95 % CI 1.4-12.7). Opioid use was not associated with unnatural or overdose death among DWH.
CONCLUSION: Opioid use was strongly associated with unnatural and overdose death among DWOH but not among DWH suggesting potential differential misclassification. Caution should be used in interpreting prevalence, incidence and risk factors for unnatural and overdose cause of death among patients with life-limiting conditions such as HIV. Published by Elsevier B.V.

Entities:  

Keywords:  Cause of death; HIV; Opioids; Overdose

Mesh:

Substances:

Year:  2020        PMID: 32417360      PMCID: PMC9580216          DOI: 10.1016/j.drugalcdep.2020.108003

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.852


  21 in total

1.  Trends in opioid analgesic abuse and mortality in the United States.

Authors:  Richard C Dart; Hilary L Surratt; Theodore J Cicero; Mark W Parrino; S Geoff Severtson; Becki Bucher-Bartelson; Jody L Green
Journal:  N Engl J Med       Date:  2015-01-15       Impact factor: 91.245

2.  Opioid Analgesic Use and Risk for Invasive Pneumococcal Diseases: A Nested Case-Control Study.

Authors:  Andrew D Wiese; Marie R Griffin; William Schaffner; C Michael Stein; Robert A Greevy; Edward F Mitchel; Carlos G Grijalva
Journal:  Ann Intern Med       Date:  2018-02-13       Impact factor: 25.391

3.  Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration.

Authors:  Colette J Smith; Lene Ryom; Rainer Weber; Philippe Morlat; Christian Pradier; Peter Reiss; Justyna D Kowalska; Stephane de Wit; Matthew Law; Wafaa el Sadr; Ole Kirk; Nina Friis-Moller; Antonella d'Arminio Monforte; Andrew N Phillips; Caroline A Sabin; Jens D Lundgren
Journal:  Lancet       Date:  2014-07-19       Impact factor: 79.321

4.  Receipt of opioid analgesics by HIV-infected and uninfected patients.

Authors:  E Jennifer Edelman; Kirsha Gordon; William C Becker; Joseph L Goulet; Melissa Skanderson; Julie R Gaither; Jennifer Brennan Braden; Adam J Gordon; Robert D Kerns; Amy C Justice; David A Fiellin
Journal:  J Gen Intern Med       Date:  2012-08-16       Impact factor: 5.128

5.  Association of Prescribed Opioids With Increased Risk of Community-Acquired Pneumonia Among Patients With and Without HIV.

Authors:  E Jennifer Edelman; Kirsha S Gordon; Kristina Crothers; Kathleen Akgün; Kendall J Bryant; William C Becker; Julie R Gaither; Cynthia L Gibert; Adam J Gordon; Brandon D L Marshall; Maria C Rodriguez-Barradas; Jeffrey H Samet; Amy C Justice; Janet P Tate; David A Fiellin
Journal:  JAMA Intern Med       Date:  2019-03-01       Impact factor: 21.873

6.  Veterans Aging Cohort Study (VACS): Overview and description.

Authors:  Amy C Justice; Elizabeth Dombrowski; Joseph Conigliaro; Shawn L Fultz; Deborah Gibson; Tamra Madenwald; Joseph Goulet; Michael Simberkoff; Adeel A Butt; David Rimland; Maria C Rodriguez-Barradas; Cynthia L Gibert; Kris Ann K Oursler; Sheldon Brown; David A Leaf; Matthew B Goetz; Kendall Bryant
Journal:  Med Care       Date:  2006-08       Impact factor: 2.983

7.  Albumin, white blood cell count, and body mass index improve discrimination of mortality in HIV-positive individuals.

Authors:  Janet P Tate; Jonathan A C Sterne; Amy C Justice
Journal:  AIDS       Date:  2019-04-01       Impact factor: 4.177

8.  Opioid dose and risk of road trauma in Canada: a population-based study.

Authors:  Tara Gomes; Donald A Redelmeier; David N Juurlink; Irfan A Dhalla; Ximena Camacho; Muhammad M Mamdani
Journal:  JAMA Intern Med       Date:  2013-02-11       Impact factor: 21.873

9.  Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies.

Authors: 
Journal:  Lancet HIV       Date:  2017-05-10       Impact factor: 12.767

10.  Trends in Deaths Involving Heroin and Synthetic Opioids Excluding Methadone, and Law Enforcement Drug Product Reports, by Census Region - United States, 2006-2015.

Authors:  Julie K O'Donnell; R Matthew Gladden; Puja Seth
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2017-09-01       Impact factor: 17.586

View more
  1 in total

1.  Naloxone receipt and overdose prevention care among people with HIV on chronic opioid therapy.

Authors:  Simeon D Kimmel; Alexander Y Walley; Sara Lodi; Leah S Forman; Jane M Liebschutz; Marlene C Lira; Theresa W Kim; Carlos Del Rio; Jeffrey H Samet; Judith I Tsui
Journal:  AIDS       Date:  2021-03-15       Impact factor: 4.632

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.